Immune evasion strategy involving propionylation by the KSHV interferon regulatory factor 1 (vIRF1).


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
04 2023
Historique:
received: 04 12 2022
accepted: 28 03 2023
revised: 18 04 2023
medline: 20 4 2023
pubmed: 7 4 2023
entrez: 6 4 2023
Statut: epublish

Résumé

Post-translational modifications (PTMs) are essential for host antiviral immune response and viral immune evasion. Among a set of novel acylations, lysine propionylation (Kpr) has been detected in both histone and non-histone proteins. However, whether protein propionylation occurs in any viral proteins and whether such modifications regulate viral immune evasion remain elusive. Here, we show that Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded viral interferon regulatory factor 1 (vIRF1) can be propionylated in lysine residues, which is required for effective inhibition of IFN-β production and antiviral signaling. Mechanistically, vIRF1 promotes its own propionylation by blocking SIRT6's interaction with ubiquitin-specific peptidase 10 (USP10) leading to its degradation via a ubiquitin-proteasome pathway. Furthermore, vIRF1 propionylation is required for its function to block IRF3-CBP/p300 recruitment and repress the STING DNA sensing pathway. A SIRT6-specific activator, UBCS039, rescues propionylated vIRF1-mediated repression of IFN-β signaling. These results reveal a novel mechanism of viral evasion of innate immunity through propionylation of a viral protein. The findings suggest that enzymes involved in viral propionylation could be potential targets for preventing viral infections.

Identifiants

pubmed: 37023208
doi: 10.1371/journal.ppat.1011324
pii: PPATHOGENS-D-22-02106
pmc: PMC10112802
doi:

Substances chimiques

Antiviral Agents 0
Interferon Regulatory Factor-1 0
Interferon Regulatory Factor-3 0
Lysine K3Z4F929H6
Sirtuins EC 3.5.1.-
viral interferon regulatory factors 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011324

Informations de copyright

Copyright: © 2023 Shi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Blood. 1996 Jul 15;88(2):645-56
pubmed: 8695812
Cell Res. 2016 Apr;26(4):457-83
pubmed: 27012466
J Virol. 2006 May;80(10):4833-46
pubmed: 16641275
Biochem Pharmacol. 2021 Jan;183:114316
pubmed: 33152343
Nature. 2004 Nov 18;432(7015):353-60
pubmed: 15525938
Oncogene. 1997 Oct 16;15(16):1979-85
pubmed: 9365244
PLoS Pathog. 2019 Jan 30;15(1):e1007578
pubmed: 30699189
Nat Struct Mol Biol. 2010 Jun;17(6):666-72
pubmed: 20495563
Nature. 2019 Oct;574(7779):575-580
pubmed: 31645732
Nat Rev Mol Cell Biol. 2014 Aug;15(8):536-50
pubmed: 25053359
Cell Rep. 2013 Dec 26;5(6):1639-49
pubmed: 24332849
Front Pharmacol. 2022 Apr 20;13:837544
pubmed: 35517808
Nat Rev Cardiol. 2020 Feb;17(2):96-115
pubmed: 31350538
J Virol. 2014 May;88(9):4987-5000
pubmed: 24554664
Cell Death Differ. 2006 Apr;13(4):539-50
pubmed: 16167067
Cell Death Differ. 2019 Oct;26(10):1970-1986
pubmed: 30670829
Blood. 1995 Aug 15;86(4):1276-80
pubmed: 7632932
J Virol. 2019 Mar 21;93(7):
pubmed: 30651359
Immunol Rev. 2012 Mar;246(1):95-106
pubmed: 22435549
Hepatology. 2018 Nov;68(5):1786-1803
pubmed: 29698567
Oncogene. 2001 Feb 15;20(7):800-11
pubmed: 11314014
J Biol Chem. 2007 Oct 12;282(41):30239-45
pubmed: 17684016
J Virol. 2001 Jul;75(13):6193-8
pubmed: 11390621
PLoS Pathog. 2015 Sep 24;11(9):e1005171
pubmed: 26402907
Cell Biosci. 2021 Dec 14;11(1):210
pubmed: 34906231
Science. 1996 Dec 6;274(5293):1739-44
pubmed: 8939871
Mol Cell Proteomics. 2009 Jan;8(1):45-52
pubmed: 18753126
Nat Rev Endocrinol. 2016 Jan;12(1):43-60
pubmed: 26503676
Nat Rev Genet. 2019 Nov;20(11):657-674
pubmed: 31358977
J Virol. 2002 Jun;76(11):5532-9
pubmed: 11991981
Int J Mol Sci. 2015 Jul 28;16(8):17193-230
pubmed: 26225966
Nat Rev Mol Cell Biol. 2015 Jan;16(1):5-17
pubmed: 25491103
Med Res Rev. 2021 Mar;41(2):1089-1137
pubmed: 33325563
Cell Death Dis. 2018 Sep 24;9(10):996
pubmed: 30250025
Nucleic Acids Res. 2014 Sep;42(15):9862-79
pubmed: 25104021
Clin Infect Dis. 2010 Aug 1;51(3):350-8
pubmed: 20583924
Angew Chem Int Ed Engl. 2017 Jan 19;56(4):1007-1011
pubmed: 27990725
Annu Rev Biochem. 2021 Jun 20;90:245-285
pubmed: 33848425
Mol Cell Proteomics. 2007 May;6(5):812-9
pubmed: 17267393
Nucleic Acids Res. 2013 Apr;41(7):4295-306
pubmed: 23435230
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4306-15
pubmed: 26199418
Nat Struct Mol Biol. 2017 Dec;24(12):1048-1056
pubmed: 29058708
J Virol. 1999 Sep;73(9):7334-42
pubmed: 10438822
Cancer Res. 2005 Mar 1;65(5):1738-47
pubmed: 15753369
J Amino Acids. 2011;2011:207691
pubmed: 22312457
Science. 1994 Dec 16;266(5192):1865-9
pubmed: 7997879
J Biol Chem. 2016 Mar 18;291(12):6281-91
pubmed: 26786098
Nat Rev Immunol. 2020 Sep;20(9):537-551
pubmed: 32203325

Auteurs

Jiale Shi (J)

Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, People's Republic of China.
Department of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.
Key Laboratory of Pathogen Biology of Jiangsu Province, Nanjing Medical University, Nanjing, People's Republic of China.

Xuemei Jia (X)

Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, People's Republic of China.

Yujia He (Y)

Department of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.

Xinyue Ma (X)

Department of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.

Xiaoyu Qi (X)

Department of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.

Wan Li (W)

Department of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.
Key Laboratory of Pathogen Biology of Jiangsu Province, Nanjing Medical University, Nanjing, People's Republic of China.

Shou-Jiang Gao (SJ)

Tumor Virology Program, UPMC Hillman Cancer Center, and Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

Qin Yan (Q)

Department of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.
Key Laboratory of Pathogen Biology of Jiangsu Province, Nanjing Medical University, Nanjing, People's Republic of China.

Chun Lu (C)

Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, People's Republic of China.
Department of Microbiology, Nanjing Medical University, Nanjing, People's Republic of China.
Key Laboratory of Pathogen Biology of Jiangsu Province, Nanjing Medical University, Nanjing, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH